Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow TREACE MEDICAL CONCEPTS, INC.

Get SEC filing alerts via email and in your feed for TREACE MEDICAL CONCEPTS, INC.

TMCI

TREACE MEDICAL CONCEPTS, INC.

About TREACE MEDICAL CONCEPTS, INC.

Treace Medical Concepts specializes in innovative surgical solutions for bunion and midfoot deformities. Its core products include the Lapiplasty 3D Bunion Correction System, Adductoplasty Midfoot Correction System, and minimally invasive procedures like Nanoplasty and Percuplasty. The company targets foot and ankle surgeons in the U.S., emphasizing clinical outcomes, surgeon training, and patient education to establish a standard of care in bunion surgery.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from TREACE MEDICAL CONCEPTS, INC.

1
1
TREACE MEDICAL CONCEPTS, INC. Treace Medical Concepts Reports $47.2 Million Revenue in Q1 2026, Net Loss Increases to $18 Million

Via official filing (AI summary) | 28 days ago | 0 comments

2
1
TREACE MEDICAL CONCEPTS, INC. Treace Medical Concepts Reports 1.6% Revenue Increase to $212.7 Million for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
TREACE MEDICAL CONCEPTS, INC. Treace Medical Concepts Reports 11.4% Revenue Growth in Q3 2025 Despite Increased Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
TREACE MEDICAL CONCEPTS, INC. Treace Medical Concepts Reports $47.4M Revenue in Q2 2025, Net Loss Improves

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
TREACE MEDICAL CONCEPTS, INC. Treace Medical Reports $52.6 Million Revenue in Q1 2025, Up 2.9% Year-Over-Year

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
TREACE MEDICAL CONCEPTS, INC. Treace Medical Concepts Reports $209.4M Revenue with Increased Losses for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
TREACE MEDICAL CONCEPTS, INC. Treace Medical Concepts Reports 10.6% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments